Intersect ENT, Inc. XENT
Set alert
28.24 0.00 0.00%
As of Apr 24, 3:47 PM ET
28.23 Day range 28.25
52-week range unavailable
- Open
- 28.25
- Prev close
- 28.24
- Mkt cap
- 0
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 28.23
- High
- 28.25
- Forward P/E
- -25.44
- Beta
- 1.53
- Short ratio
- 6.49
- Inst. own
- 93.60%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 16, 2022
- 50-d avg
- 27.83
- 200-d avg
- 27.38
- 1y target
- 28.25
Analyst view
Consensus: hold
Hold
Price target (mean) 28.25
Ratings (0m) 11 8 buy · 3 hold · 0 sell
- Strong buy6
- Buy2
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 11
- 1 month ago 2
- 2 months ago 2
- 3 months ago 11
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.32 | -0.32 – -0.32 | -0.52 | +38.5% | 31.90M | +13.9% | 1 |
| Next quarter | -0.29 | -0.29 – -0.29 | -0.49 | +40.8% | 35.45M | 0.0% | 1 |
| Current year | -1.64 | -1.64 – -1.64 | -4.80 | +65.8% | 130.84M | +22.6% | 1 |
| Next year | 0.00 | 0.00 – 0.00 | -1.64 | 0.0% | 180.00M | +37.6% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 12, 2021 | SVB Leerink | Downgrade | Outperform | Market Perform |
| Aug 10, 2021 | BTIG | Downgrade | Buy | Neutral |
| Aug 9, 2021 | Canaccord Genuity | Downgrade | Buy | Hold |
| Aug 9, 2021 | Guggenheim | Downgrade | Buy | Neutral |
| Jun 24, 2021 | SVB Leerink | Upgrade | Market Perform | Outperform |
| May 11, 2021 | SVB Leerink | Maintained | — | Market Perform |
| Mar 10, 2021 | SVB Leerink | Maintained | — | Market Perform |
| Jan 11, 2021 | Canaccord Genuity | Upgrade | Hold | Buy |
| Dec 3, 2020 | SVB Leerink | Maintained | — | Market Perform |
| Nov 19, 2020 | BTIG | Upgrade | Neutral | Buy |
| Nov 3, 2020 | SVB Leerink | Maintained | — | Market Perform |
| Oct 8, 2020 | JP Morgan | Downgrade | Overweight | Neutral |
| Aug 5, 2020 | SVB Leerink | Maintained | — | Market Perform |
| Jun 29, 2020 | SVB Leerink | Maintained | — | Market Perform |
| Jun 24, 2020 | Oppenheimer | Initiated | — | Perform |
| May 12, 2020 | SVB Leerink | Maintained | — | Market Perform |
| May 12, 2020 | JP Morgan | Maintained | — | Overweight |
| May 12, 2020 | Canaccord Genuity | Downgrade | Buy | Hold |
| Apr 15, 2020 | B of A Securities | Downgrade | Buy | Underperform |
| Dec 20, 2019 | JP Morgan | Maintained | — | Overweight |
| Aug 2, 2019 | Guggenheim | Downgrade | Buy | Neutral |
| Aug 2, 2019 | Piper Jaffray | Downgrade | Overweight | Neutral |
| Jul 10, 2019 | Northland Securities | Upgrade | Underperform | Market Perform |
| Jun 21, 2019 | Berenberg | Downgrade | Buy | Hold |
| May 7, 2019 | Northland | Downgrade | Market Perform | Underperform |
| May 7, 2019 | SVB Leerink | Downgrade | Outperform | Market Perform |
| Feb 26, 2019 | Canaccord Genuity | Maintained | Buy | Buy |
| Jan 2, 2018 | JP Morgan | Upgrade | Neutral | Overweight |
| Sep 13, 2017 | Canaccord Genuity | Maintained | — | Buy |
| Aug 2, 2017 | Deutsche Bank | Maintained | — | Buy |